BHCM
ROIV icon

Brevan Howard Capital Management’s Roivant Sciences ROIV Stock Holding History

Brevan Howard Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3M Buy
517,621
+401,019
+344% +$11.9M 0.14% 109
2026
Q1 		$3.23M Buy
+116,602
New +$3M 0.03% 383
2024
Q4 		– Sell
-58,124
Closed -$671K – 1376
2024
Q3 		$671K Sell
58,124
-32,602
-36% -$371K ﹤0.01% 601
2024
Q2 		$959K Buy
+90,726
New +$994K 0.01% 391

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Brevan Howard Capital Management's ROIV Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Roivant Sciences (ROIV) stake by 344% in Q2 2026, buying an estimated $11.9M and bringing the position to 517,621 shares worth $18.3M. The position accounts for 0.14% of the portfolio, ranked #109.

Brevan Howard Capital Management first reported a position in ROIV in Q2 2024 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Brevan Howard Capital Management held 517,621 shares of Roivant Sciences worth $18.3M as of Q2 2026.
  • Brevan Howard Capital Management bought 401,019 Roivant Sciences shares in Q2 2026, an estimated $11.9M.
  • Roivant Sciences made up 0.14% of Brevan Howard Capital Management's portfolio in Q2 2026, its #109 holding.
  • Brevan Howard Capital Management first reported a position in Roivant Sciences in Q2 2024 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.